Alzheimer’s Disease Combination Therapy

This study evaluates the effect of LY3002813 on brain scans. The study will evaluate the safety of LY3002813 by looking at adverse events (side effects). The study will also look at the effect the body has on LY3002813. Study participants will have mild cognitive impairment (MCI) due to AD or mild to moderate AD.

If you are someone you love is suffering from memory loss, you may be eligible for:

• Investigational drugs

• Study-related care from a local study doctor

• Reimbursement for time and travel expenses

You may qualify for this research study if you:

• Are at least 50 years of age

• Are experiencing noticeable changes in your memory

• Have a regular informant/study partner available

Contact Us!